1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Radiation Therapy 1.2.3 Chemotherapy 1.2.4 Hormone Therapy 1.2.5 Investigational Therapy 1.3 Market by Application 1.3.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Cancer Research Institutes 1.3.4 Ambulatory Surgical Centers 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Perspective (2016-2027) 2.2 Advanced Renal Cell Carcinoma Therapeutics Growth Trends by Regions 2.2.1 Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Advanced Renal Cell Carcinoma Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Advanced Renal Cell Carcinoma Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Advanced Renal Cell Carcinoma Therapeutics Industry Dynamic 2.3.1 Advanced Renal Cell Carcinoma Therapeutics Market Trends 2.3.2 Advanced Renal Cell Carcinoma Therapeutics Market Drivers 2.3.3 Advanced Renal Cell Carcinoma Therapeutics Market Challenges 2.3.4 Advanced Renal Cell Carcinoma Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Advanced Renal Cell Carcinoma Therapeutics Players by Revenue 3.1.1 Global Top Advanced Renal Cell Carcinoma Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Advanced Renal Cell Carcinoma Therapeutics Revenue 3.4 Global Advanced Renal Cell Carcinoma Therapeutics Market Concentration Ratio 3.4.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Advanced Renal Cell Carcinoma Therapeutics Revenue in 2020 3.5 Advanced Renal Cell Carcinoma Therapeutics Key Players Head office and Area Served 3.6 Key Players Advanced Renal Cell Carcinoma Therapeutics Product Solution and Service 3.7 Date of Enter into Advanced Renal Cell Carcinoma Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Advanced Renal Cell Carcinoma Therapeutics Breakdown Data by Type 4.1 Global Advanced Renal Cell Carcinoma Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Advanced Renal Cell Carcinoma Therapeutics Forecasted Market Size by Type (2022-2027) 5 Advanced Renal Cell Carcinoma Therapeutics Breakdown Data by Application 5.1 Global Advanced Renal Cell Carcinoma Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Advanced Renal Cell Carcinoma Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Advanced Renal Cell Carcinoma Therapeutics Market Size (2016-2027) 6.2 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type 6.2.1 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2027) 6.3 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application 6.3.1 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2027) 6.4 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country 6.4.1 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size (2016-2027) 7.2 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type 7.2.1 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2027) 7.3 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application 7.3.1 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2027) 7.4 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Country 7.4.1 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Type 8.2.1 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Application 8.3.1 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Region 8.4.1 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size (2016-2027) 9.2 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type 9.2.1 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application 9.3.1 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country 9.4.1 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Type 10.2.1 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Application 10.3.1 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Country 10.4.1 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Acceleron Pharma 11.1.1 Acceleron Pharma Company Details 11.1.2 Acceleron Pharma Business Overview 11.1.3 Acceleron Pharma Advanced Renal Cell Carcinoma Therapeutics Introduction 11.1.4 Acceleron Pharma Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.1.5 Acceleron Pharma Recent Development 11.2 Argos Therapeutics 11.2.1 Argos Therapeutics Company Details 11.2.2 Argos Therapeutics Business Overview 11.2.3 Argos Therapeutics Advanced Renal Cell Carcinoma Therapeutics Introduction 11.2.4 Argos Therapeutics Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.2.5 Argos Therapeutics Recent Development 11.3 AVEO Pharmaceuticals 11.3.1 AVEO Pharmaceuticals Company Details 11.3.2 AVEO Pharmaceuticals Business Overview 11.3.3 AVEO Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Introduction 11.3.4 AVEO Pharmaceuticals Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.3.5 AVEO Pharmaceuticals Recent Development 11.4 Bayer 11.4.1 Bayer Company Details 11.4.2 Bayer Business Overview 11.4.3 Bayer Advanced Renal Cell Carcinoma Therapeutics Introduction 11.4.4 Bayer Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.4.5 Bayer Recent Development 11.5 Bristol-Myers Squibb Company 11.5.1 Bristol-Myers Squibb Company Company Details 11.5.2 Bristol-Myers Squibb Company Business Overview 11.5.3 Bristol-Myers Squibb Company Advanced Renal Cell Carcinoma Therapeutics Introduction 11.5.4 Bristol-Myers Squibb Company Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.5.5 Bristol-Myers Squibb Company Recent Development 11.6 Eisai 11.6.1 Eisai Company Details 11.6.2 Eisai Business Overview 11.6.3 Eisai Advanced Renal Cell Carcinoma Therapeutics Introduction 11.6.4 Eisai Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.6.5 Eisai Recent Development 11.7 Exelixi 11.7.1 Exelixi Company Details 11.7.2 Exelixi Business Overview 11.7.3 Exelixi Advanced Renal Cell Carcinoma Therapeutics Introduction 11.7.4 Exelixi Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.7.5 Exelixi Recent Development 11.8 Genentech 11.8.1 Genentech Company Details 11.8.2 Genentech Business Overview 11.8.3 Genentech Advanced Renal Cell Carcinoma Therapeutics Introduction 11.8.4 Genentech Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.8.5 Genentech Recent Development 11.9 Immatics Biotechnologies 11.9.1 Immatics Biotechnologies Company Details 11.9.2 Immatics Biotechnologies Business Overview 11.9.3 Immatics Biotechnologies Advanced Renal Cell Carcinoma Therapeutics Introduction 11.9.4 Immatics Biotechnologies Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.9.5 Immatics Biotechnologies Recent Development 11.10 Merck 11.10.1 Merck Company Details 11.10.2 Merck Business Overview 11.10.3 Merck Advanced Renal Cell Carcinoma Therapeutics Introduction 11.10.4 Merck Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.10.5 Merck Recent Development 11.11 Novartis 11.11.1 Novartis Company Details 11.11.2 Novartis Business Overview 11.11.3 Novartis Advanced Renal Cell Carcinoma Therapeutics Introduction 11.11.4 Novartis Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.11.5 Novartis Recent Development 11.12 Ono Pharmaceutical 11.12.1 Ono Pharmaceutical Company Details 11.12.2 Ono Pharmaceutical Business Overview 11.12.3 Ono Pharmaceutical Advanced Renal Cell Carcinoma Therapeutics Introduction 11.12.4 Ono Pharmaceutical Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.12.5 Ono Pharmaceutical Recent Development 11.13 Pfizer 11.13.1 Pfizer Company Details 11.13.2 Pfizer Business Overview 11.13.3 Pfizer Advanced Renal Cell Carcinoma Therapeutics Introduction 11.13.4 Pfizer Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.13.5 Pfizer Recent Development 11.14 Rexahn Pharmaceuticals 11.14.1 Rexahn Pharmaceuticals Company Details 11.14.2 Rexahn Pharmaceuticals Business Overview 11.14.3 Rexahn Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Introduction 11.14.4 Rexahn Pharmaceuticals Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.14.5 Rexahn Pharmaceuticals Recent Development 11.15 Hoffmann-La Roche 11.15.1 Hoffmann-La Roche Company Details 11.15.2 Hoffmann-La Roche Business Overview 11.15.3 Hoffmann-La Roche Advanced Renal Cell Carcinoma Therapeutics Introduction 11.15.4 Hoffmann-La Roche Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) 11.15.5 Hoffmann-La Roche Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Advanced Renal Cell Carcinoma Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Radiation Therapy Table 3. Key Players of Chemotherapy Table 4. Key Players of Hormone Therapy Table 5. Key Players of Investigational Therapy Table 6. Global Advanced Renal Cell Carcinoma Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions (2016-2021) Table 10. Global Advanced Renal Cell Carcinoma Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions (2022-2027) Table 12. Advanced Renal Cell Carcinoma Therapeutics Market Trends Table 13. Advanced Renal Cell Carcinoma Therapeutics Market Drivers Table 14. Advanced Renal Cell Carcinoma Therapeutics Market Challenges Table 15. Advanced Renal Cell Carcinoma Therapeutics Market Restraints Table 16. Global Advanced Renal Cell Carcinoma Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Players (2016-2021) Table 18. Global Top Advanced Renal Cell Carcinoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Advanced Renal Cell Carcinoma Therapeutics as of 2020) Table 19. Ranking of Global Top Advanced Renal Cell Carcinoma Therapeutics Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Advanced Renal Cell Carcinoma Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Advanced Renal Cell Carcinoma Therapeutics Product Solution and Service Table 23. Date of Enter into Advanced Renal Cell Carcinoma Therapeutics Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 26. Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Type (2016-2021) Table 27. Global Advanced Renal Cell Carcinoma Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Advanced Renal Cell Carcinoma Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Application (2016-2021) Table 31. Global Advanced Renal Cell Carcinoma Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 34. North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 36. North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 63. Acceleron Pharma Company Details Table 64. Acceleron Pharma Business Overview Table 65. Acceleron Pharma Advanced Renal Cell Carcinoma Therapeutics Product Table 66. Acceleron Pharma Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 67. Acceleron Pharma Recent Development Table 68. Argos Therapeutics Company Details Table 69. Argos Therapeutics Business Overview Table 70. Argos Therapeutics Advanced Renal Cell Carcinoma Therapeutics Product Table 71. Argos Therapeutics Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 72. Argos Therapeutics Recent Development Table 73. AVEO Pharmaceuticals Company Details Table 74. AVEO Pharmaceuticals Business Overview Table 75. AVEO Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Product Table 76. AVEO Pharmaceuticals Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 77. AVEO Pharmaceuticals Recent Development Table 78. Bayer Company Details Table 79. Bayer Business Overview Table 80. Bayer Advanced Renal Cell Carcinoma Therapeutics Product Table 81. Bayer Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 82. Bayer Recent Development Table 83. Bristol-Myers Squibb Company Company Details Table 84. Bristol-Myers Squibb Company Business Overview Table 85. Bristol-Myers Squibb Company Advanced Renal Cell Carcinoma Therapeutics Product Table 86. Bristol-Myers Squibb Company Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 87. Bristol-Myers Squibb Company Recent Development Table 88. Eisai Company Details Table 89. Eisai Business Overview Table 90. Eisai Advanced Renal Cell Carcinoma Therapeutics Product Table 91. Eisai Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 92. Eisai Recent Development Table 93. Exelixi Company Details Table 94. Exelixi Business Overview Table 95. Exelixi Advanced Renal Cell Carcinoma Therapeutics Product Table 96. Exelixi Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 97. Exelixi Recent Development Table 98. Genentech Company Details Table 99. Genentech Business Overview Table 100. Genentech Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 101. Genentech Recent Development Table 102. Immatics Biotechnologies Company Details Table 103. Immatics Biotechnologies Business Overview Table 104. Immatics Biotechnologies Advanced Renal Cell Carcinoma Therapeutics Product Table 105. Immatics Biotechnologies Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 106. Immatics Biotechnologies Recent Development Table 107. Merck Company Details Table 108. Merck Business Overview Table 109. Merck Advanced Renal Cell Carcinoma Therapeutics Product Table 110. Merck Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 111. Merck Recent Development Table 112. Novartis Company Details Table 113. Novartis Business Overview Table 114. Novartis Advanced Renal Cell Carcinoma Therapeutics Product Table 115. Novartis Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 116. Novartis Recent Development Table 117. Ono Pharmaceutical Company Details Table 118. Ono Pharmaceutical Business Overview Table 119. Ono Pharmaceutical Advanced Renal Cell Carcinoma Therapeutics Product Table 120. Ono Pharmaceutical Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 121. Ono Pharmaceutical Recent Development Table 122. Pfizer Company Details Table 123. Pfizer Business Overview Table 124. Pfizer Advanced Renal Cell Carcinoma Therapeutics Product Table 125. Pfizer Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 126. Pfizer Recent Development Table 127. Rexahn Pharmaceuticals Company Details Table 128. Rexahn Pharmaceuticals Business Overview Table 129. Rexahn Pharmaceuticals Advanced Renal Cell Carcinoma Therapeutics Product Table 130. Rexahn Pharmaceuticals Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 131. Rexahn Pharmaceuticals Recent Development Table 132. Hoffmann-La Roche Company Details Table 133. Hoffmann-La Roche Business Overview Table 134. Hoffmann-La Roche Advanced Renal Cell Carcinoma Therapeutics Product Table 135. Hoffmann-La Roche Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) & (US$ Million) Table 136. Hoffmann-La Roche Recent Development Table 137. Research Programs/Design for This Report Table 138. Key Data Information from Secondary Sources Table 139. Key Data Information from Primary Sources List of Figures Figure 1. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Radiation Therapy Features Figure 3. Chemotherapy Features Figure 4. Hormone Therapy Features Figure 5. Investigational Therapy Features Figure 6. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Application: 2020 VS 2027 Figure 7. Hospitals Case Studies Figure 8. Cancer Research Institutes Case Studies Figure 9. Ambulatory Surgical Centers Case Studies Figure 10. Others Case Studies Figure 11. Advanced Renal Cell Carcinoma Therapeutics Report Years Considered Figure 12. Global Advanced Renal Cell Carcinoma Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Advanced Renal Cell Carcinoma Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions: 2020 VS 2027 Figure 15. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions (2022-2027) Figure 16. Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Players in 2020 Figure 17. Global Top Advanced Renal Cell Carcinoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Advanced Renal Cell Carcinoma Therapeutics as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Advanced Renal Cell Carcinoma Therapeutics Revenue in 2020 Figure 19. Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Type (2016-2021) Figure 20. Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Type (2022-2027) Figure 21. North America Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2016-2027) Figure 23. North America Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2016-2027) Figure 24. North America Advanced Renal Cell Carcinoma Therapeutics Market Share by Country (2016-2027) Figure 25. United States Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2016-2027) Figure 29. Europe Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2016-2027) Figure 30. Europe Advanced Renal Cell Carcinoma Therapeutics Market Share by Country (2016-2027) Figure 31. Germany Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2016-2027) Figure 39. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2016-2027) Figure 40. Asia-Pacific Advanced Renal Cell Carcinoma Therapeutics Market Share by Region (2016-2027) Figure 41. China Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2016-2027) Figure 49. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2016-2027) Figure 50. Latin America Advanced Renal Cell Carcinoma Therapeutics Market Share by Country (2016-2027) Figure 51. Mexico Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2016-2027) Figure 55. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2016-2027) Figure 56. Middle East & Africa Advanced Renal Cell Carcinoma Therapeutics Market Share by Country (2016-2027) Figure 57. Turkey Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Advanced Renal Cell Carcinoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Acceleron Pharma Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 61. Argos Therapeutics Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 62. AVEO Pharmaceuticals Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 63. Bayer Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 64. Bristol-Myers Squibb Company Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 65. Eisai Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 66. Exelixi Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 67. Genentech Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 68. Immatics Biotechnologies Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 69. Merck Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 70. Novartis Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 71. Ono Pharmaceutical Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 72. Pfizer Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 73. Rexahn Pharmaceuticals Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 74. Hoffmann-La Roche Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2016-2021) Figure 75. Bottom-up and Top-down Approaches for This Report Figure 76. Data Triangulation Figure 77. Key Executives Interviewed

Acceleron Pharma Argos Therapeutics AVEO Pharmaceuticals Bayer Bristol-Myers Squibb Company Eisai Exelixi Genentech Immatics Biotechnologies Merck Novartis Ono Pharmaceutical Pfizer Rexahn Pharmaceuticals Hoffmann-La Roche